21
Feb
22
Feb

Dublin

Presented by

IPHA IPHA
BPCI BPCI
NIBRT NIBRT

Event Sponsors

PWC PWC

Agency partners

Intertrade Ireland Intertrade Ireland

Plenary sessions

07.45
Registration
08.30
Seamus Fives, Chairman, BioPharmaChem Ireland
Opening Address
08.35
Mary Mitchell O’Connor TD, Minister of Jobs, Enterprise and Innovation
Opening address - Global innovation from and in Ireland
08.45
Simon Hamilton, MLA, Minister for the Economy
Address Minister for the Economy
08.55
Dr Michael Kopcha, Director Office of Pharmaceutical Quality, FDA
Aligning policy regulation, innovation and quality in pharmaceuticals
09.45
From lab to bedside in the future - the convergence of manufacturing and care
Chaired by Johnathon Marshall, Partner, PwC
- Prof Charles Cooney, FT Haslam Prof of Chemical Engineering, MIT
- Dr Mike Thien, SVP Global Technology and Commercialisation, MSD
- Dr Gerard Fox, Senior Director & Head, Calico Collaboration, AbbVie
- Dr Bernadette Doyle, Vice President, Global Technical & NPI, Global Manufacturing and Supply, GlaxoSmithKline
Q+A
11.15
Networking Break
11.45
Limitless? Harnessing the power of the immune system
Chaired by Nigel Darby, Advisor, GE Healthcare Life Sciences
- Prof Luke O'Neill, Chair of Biochemistry,Trinity College Dublin
- Dr Tom Lillie, VP of Clinical Research for Europe MSD
- Dr Anthony J. Coyle, SVP/CSO Centers for Therapeutic Innovation, Pfizer
- Elcin Ergun, Executive Vice President, Head of New Business, Healthcare, Merck
Q+A
13.15
Simon Harris TD, Minister for Health
Address
13.30
Networking Lunch
14.30
Translational Science and Precision Medicine
Chaired by Dr Darrin Morrissey, Director of Programmes, Science Foundation Ireland
- Prof Garret FitzGerald, Director, Institute for Translational Medicine and Therapeutics, University of Pennsylvania
- Prof Damian O’Connell, Senior Vice President, Drug Discovery – Global Head of Clinical Sciences, Bayer Pharma AG
- Dr Craig Tendler, VP Late-Stage Development and Global Medical Affairs for Oncology, Hematology and Supportive Care, Janssen
- Damian Page, Associate Group International Scientific Director, Roche Group
Q+A
16.00
Prof Patrick Johnston, President and Vice Chancellor,Queens University Belfast
Accelerating scientific discovery to clinical application – dawn of a new era
16.30
Sir Andrew Dillon, Chief Executive, NICE
How NICE will influence and facilitate pharmaceutical innovation in health services
17.15
Dr Leisha Daly, President, IPHA
End note address
Close